发明名称 Treating protein folding disorders with small molecule CFTR correctors
摘要 Novel CFTR corrector compounds that are effective in rescuing halide efflux in a cell are provided. Also provided are methods for treating protein folding disorders (e.g., cystic fibrosis). The methods include administering a CFTR corrector compound or pharmaceutically acceptable salt or prodrug thereof. Methods of screening for CFTR corrector compounds are also described herein. The methods of screening include contacting a cell that endogenously expresses a CFTR mutation with the compound to be screened and detecting a rescue of halide efflux from the cell.
申请公布号 US9221840(B2) 申请公布日期 2015.12.29
申请号 US201214117705 申请日期 2012.05.17
申请人 DISCOVERYBIOMED INC. 发明人 Schwiebert Erik M.
分类号 A61K31/519;C07D513/04;A61K31/513;G01N33/50;G01N33/84;C07D239/95;C07D487/04;C07D223/04;C07D239/42;C07D241/52;C07D251/46;C07D417/04;C07D473/06 主分类号 A61K31/519
代理机构 Kilpatrick Townsend & Stockton, LLP 代理人 Kilpatrick Townsend & Stockton, LLP
主权项 1. A method for the treatment of a protein folding disorder in a subject, comprising: administering to the subject a CFTR corrector compound, wherein the CFTR corrector compound has the following structure: or a pharmaceutically acceptable salt thereof, wherein: R1 is hydrogen, halogen, alkoxy, substituted or unsubstituted amino, or substituted or unsubstituted alkyl; andR2, R3, and R4 are each independently substituted or unsubstituted alkyl.
地址 Birmingham AL US